In 1980, the number of Americans who died annually from diabetes was near 35,000.
Today, that statistic is more than 100,000.
How can that be?
What has the American Diabetes Association (ADA), the Federal Drug Administration (FDA), and Big Pharma been doing to reduce that number?
It is not surprising, after what we have experienced during the days of Anthony Fauci and the 2020-2022 mRNA pandemic, that through the ADA’s convenient arrangements with the medical industry, Big Pharma quadrupled in profits.
The entire pharmaceutical industry had an estimated $58 billion in annual sales in 2017.
● In 2022, just one company, Pfizer of course, surpassed $100 billion in revenue.
● By 2023, Merck reached a revenue climb to $60.115 billion. In 2024, with their “anti-diabetic drug” Januvia, Merck & Co. projects 2024 sales to be up to $64.2 billion.
● Johnson & Johnson’s pharma division revenue grew from $45.6 billion in 2020 to $54.8 billion in 2023.
● One notable example of the FDA, CDC and Big Pharma connection is illustrated with Merck. They have the audacity to charge $200,000 for the life-saving cancer drug Keytruda. It was developed using tax-payer dollars. That means the federal government has the little-known power to lower the price by taking Merck’s patent and giving it away. Why don’t they?
Winners vs. Losers
The winners with ADA are not only the FDA, CDC, NIH, and pharmaceutical giants, but include medical device and food companies, all who donate generously to the ADA in exchange for endorsements.
The losers are the millions of people with diabetes who suffer amputations, blindness, neuropathy, often daily shoot themselves with insulin and eat carbohydrate-rich foods because they simply are not informed about their healthier options.
Diabetes is a national scandal hiding in plain sight. Despite infinite medical innovations, including glucose-lowering drugs, fast- and slow-acting insulin, A1C tests, continuous glucose monitors and insulin pumps, 65,000 more Americans die from the condition annually than they did in 1980.
Between 2017 and 2024, more than 50 pharmaceutical and device manufacturers contributed over $134M to the American Diabetes Association, or about 20% of its total funding.
In 2021, Patients for Affordable Drugs published a landmark report exploring connections between 15 patient advocacy groups and the pharmaceutical industry.
● The ADA scored lowest because it: “Accepts funding from pharma industry” and also because it “Has board members with financial ties to pharma industry; Shares lobbyist and/or lobby firm with pharma,” the report said.
● In 2021, the Patients for Affordable Drugs report, found that a third “of the members of the ADA board of directors have financial ties to the pharmaceutical industry”.
“HgbA1c is a long-term, laboratory-performed test used to estimate blood sugar levels over a previous two- to three-month period,” explains John McDougall, MD.
“Normal HgbA1c is considered less than 6% and levels can rise as high as 14%,” he said. “Most physicians, based on no meaningful scientific evidence—that the target level for treatment is between 7% and 8%.”
Dr. McDougall, a physician, speaker, and best-selling author who teaches the importance of a whole food, starch-based diet in order to halt, reverse and heal chronic disease, revealed that Big Pharma and ADA’s “financially rewarding system works well until the blood-sugar-lowering medicines, along with the gadgets and tests they rely on, are proven useless and dangerous.”
“Unfortunately for the patients, industry fights back, defending their treasure-trove by hiring pricey medical experts, factoring in expected lawsuits, and exaggerating the benefits and minimizing the harms of their products,” he continued.
“Almost all physicians these days practice under the belief that metformin is the first-line medication for diabetes…” Dr. McDougall said. “However, the truth is that since 2001 the evidence supporting the cardiovascular benefits of diabetic medications has been recognized as seriously flawed.”
“Furthermore, the universal claims that metformin reduces cardiovascular disease are primarily based on a small subgroup of patients (n = 342) from the 1998 United Kingdom Prospective Diabetes Study (UKPDS) conducted more than three decades ago.”
McDougall’s program centers on a diet of 90% starchy plant foods—including whole grains and whole-grain products—and 10% of a wide assortment of vegetables and fruit.
Medical Disclaimer: This information is provided for general informational purposes only. It is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information provided by us to diagnose or treat any health issues without consulting a qualified healthcare professional.
☆☆☆☆☆
IN GOD WE TRUST
Thanks for supporting independent true journalism with a small tip. Dodie & Jack
Green Pasture Here!
Use Code CLEVER10 for a 10% discount online to be other Green Pasture products today!
.
CINDY LEAL MASSEY, TEXAS AUTHOR
Clever Journeys 
Inflammation typically catapults diseases. I agree that anti-inflammatory foods, spices, herbs, etc., can help disarm them. I once visited a doctor to get his opinion on my trigger thumbs. He told me he’d have to surgically correct the problem. I asked him what caused it. He said the tendon sheaths were swollen and inflamed so the tendons couldn’t slide through. I thanked him for his advise, ate a bunch of blueberries, avoided inflammatory foods, and was fine in two days. 🙂
LikeLiked by 2 people